ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "antibodies and inflammatory arthritis"

  • Abstract Number: 2491 • ACR/ARHP Annual Meeting 2016

    Is It  Possible to Predict Which Patients Treated with Biologic Agents for Rheumatic Diseases Will Develop Anti-Drug Antibodies ?

    Pascal Zufferey1, Melanie Favre dit Jeanfavre2, Alexandre Dumusc3, Charles Benaim4, Matthieu Perreau5 and Alexander K. So Sr.6, 1Rhu /Dal .Chuv, Rheumatology, Lausanne, Switzerland, 2DAL, RHU, Lausanne, Switzerland, 3DAL, RHU/CHUV, Lausanne, Switzerland, 4DAL, MPR, Lausanne, Switzerland, 5Medecine /CHUV, Immunology, Lausanne, Switzerland, 6Service De Rhumatologie, CHUV, Lausanne, Switzerland

    Background/Purpose: All biologic agents (bDMARDs) currently used in rheumatology can induce anti-drug antibodies (ADAB), which will influence the drug levels and the drug effectiveness. Why…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology